已收盘 07-18 16:00:00 美东时间
-0.060
-0.41%
Companies in the Healthcare sector have received a lot of coverage today as ana...
07-02 14:40
Liquidia Technologies ( ($LQDA) ) has issued an update. On July 1, 2025, Liquid...
07-02 04:50
Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) - $0.126003. Payable Jul 07; for shareholders of record Jun 30; ex-div Jun 30. More on The Trade Desk's Amazon Threat Is Misguided TD Bank: 2025's...
06-30 22:54
Liquidia Corporation received an additional $50 million under its sixth amendment to its financing agreement with Healthcare Royalty (HCRx), following the denial of United Therapeutics’ request for a preliminary injunction against Liquidia and the first commercial sale of YUTREPIA™ (treprostinil) inhalation powder. YUTREPIA is indicated for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstit...
06-23 20:34
普拉格能源:周内累涨33%,与乌兹别克斯坦达成50亿美元交易;Oklo Inc:周内累涨26%,获得国防部核反应堆合同。
06-14 10:25
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140203048973164544.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group:上调Datavault AI(DVLT)评级至"买入",目标价3美元</p> <p>• 蒙特利尔银行:维持DoubleVerify Holdings(DV)"跑赢大市"评级,目标价从25美元升至26
06-13 09:33
Wells Fargo analyst Tiago Fauth maintains Liquidia (NASDAQ:LQDA) with a Overweight and raises the price target from $23 to $25.
06-12 21:08
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
06-12 15:20
Insmed (NASDAQ:INSM) announced Tuesday that TPIP, its experimental therapy for pulmonary arterial hypertension, succeeded in a mid-stage trial, sending the shares of its rivals Liquidia (NASDAQ:LQDA) ...
06-10 19:58
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136585934532136961.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Vera Therapeutics(VERA)"买入"评级,目标价从75美元升至85美元</p> <p>• Ascendiant Capital:维持60 Degrees
06-03 09:06